$CERS
CERUS CORP Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000119312515370158 Filed on November 06, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$9.656M	$8.045M	$10.36M
YoY Change	0.72%	-22.36%	-1.71%
Cost Of Revenue	$6.160M	$5.560M	$5.689M
YoY Change	-6.53%	-2.27%	-16.66%
Gross Profit	$3.494M	$2.485M	$4.673M
YoY Change	16.58%	-46.82%	25.75%
Gross Profit Margin	36.18%	30.89%	45.1%
Selling, General & Admin	$11.28M	$10.93M	$8.724M
YoY Change	5.52%	25.31%	12.89%
% of Gross Profit	322.84%	439.92%	186.69%
Research & Development	$7.160M	$7.689M	$7.250M
YoY Change	37.96%	6.06%	66.17%
% of Gross Profit	204.92%	309.42%	155.15%
Depreciation & Amortization	$470.0K	$390.0K	$370.0K
YoY Change	9.3%	5.41%	184.62%
% of Gross Profit	13.45%	15.69%	7.92%
Operating Expenses	$18.49M	$18.67M	$16.02M
YoY Change	16.07%	16.52%	31.98%
Operating Profit	-$15.00M	-$16.19M	-$11.35M
YoY Change	15.95%	42.6%	34.73%
Interest Expense	-$1.550M	$505.0K	$249.0K
YoY Change	-77.57%	102.81%	507.32%
% of Operating Profit
Other Income/Expense, Net	$40.00K	$601.0K	$600.0K
YoY Change	-116.67%	0.17%	-104.99%
Pretax Income	-$16.51M	-$15.59M	-$10.75M
YoY Change	-17.78%	44.96%	-47.4%
Income Tax	-$1.750M	$95.00K	$8.000K
% Of Pretax Income
Net Earnings	-$14.76M	-$15.68M	-$10.76M
YoY Change	-26.89%	45.74%	-47.52%
Net Earnings / Revenue	-152.82%	-194.9%	-103.83%
Basic Earnings Per Share	-$0.15	-$0.16	-$0.14
Diluted Earnings Per Share	-$0.15	-$0.17	-$0.16
COMMON SHARES
Basic Shares Outstanding	97.14M shares	96.86M shares	75.19M shares
Diluted Shares Outstanding		97.61M shares	76.10M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$96.72M	$99.76M	$47.60M
YoY Change	88.55%	109.59%	-10.69%
Cash & Equivalents	$71.02M	$50.80M	$22.34M
Short-Term Investments	$25.70M	$48.97M	$25.20M
Other Short-Term Assets	$4.755M	$953.0K	$2.429M
YoY Change	146.12%	-60.77%	516.5%
Inventory	$10.81M	$12.84M	$13.50M
Prepaid Expenses	$1.166M	$1.535M	$1.780M
Receivables	$5.794M	$5.646M	$7.366M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$130.4M	$128.4M	$72.65M
YoY Change	74.14%	76.76%	-2.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.549M	$3.712M	$3.882M
YoY Change	-6.14%	-4.38%	110.06%
Goodwill	$1.316M	$1.316M	$1.316M
YoY Change	0.0%	0.0%	0.0%
Intangibles			$1.193M
YoY Change			-14.48%
Long-Term Investments
YoY Change
Other Assets	$2.579M	$123.0K	$51.00K
YoY Change	1690.97%	141.18%	-29.17%
Total Long-Term Assets	$8.996M	$6.765M	$6.743M
YoY Change	30.55%	0.33%	36.58%
TOTAL ASSETS
Total Short-Term Assets	$130.4M	$128.4M	$72.65M
Total Long-Term Assets	$8.996M	$6.765M	$6.743M
Total Assets	$139.4M	$135.2M	$79.40M
YoY Change	70.47%	70.27%	-0.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.217M	$6.813M	$4.115M
YoY Change	-47.21%	65.57%	0.96%
Accrued Expenses	$9.853M	$8.108M	$12.55M
YoY Change	16.69%	-35.38%	4.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.000M	$1.400M	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$21.86M	$19.92M	$21.15M
YoY Change	-25.1%	-5.84%	-50.33%
LONG-TERM LIABILITIES
Long-Term Debt	$16.80M	$18.40M	$9.900M
YoY Change	69.7%	85.86%
Other Long-Term Liabilities	$1.263M	$1.215M	$998.0K
YoY Change	16.84%	21.74%	-10.89%
Total Long-Term Liabilities	$1.263M	$1.215M	$998.0K
YoY Change	16.84%	21.74%	-10.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.86M	$19.92M	$21.15M
Total Long-Term Liabilities	$1.263M	$1.215M	$998.0K
Total Liabilities	$44.64M	$39.67M	$32.12M
YoY Change	10.89%	23.5%	-26.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$597.8M	-$583.1M	-$521.8M
YoY Change	10.31%	11.75%	4.91%
Common Stock	$685.3M	$673.8M	$77.00K
YoY Change	17.45%	874900.0%	10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$94.77M	$95.52M	$47.28M
YoY Change
Total Liabilities & Shareholders Equity	$139.4M	$135.2M	$79.40M
YoY Change	70.47%	70.27%	-0.06%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$14.76M	-$15.68M	-$10.76M
YoY Change	-26.89%	45.74%	-47.52%
Depreciation, Depletion And Amortization	$470.0K	$390.0K	$370.0K
YoY Change	9.3%	5.41%	184.62%
Cash From Operating Activities	-$8.790M	-$11.86M	-$11.74M
YoY Change	1.85%	1.02%	92.78%
INVESTING ACTIVITIES
Capital Expenditures	-$160.0K	-$230.0K	-$600.0K
YoY Change	100.0%	-61.67%	130.77%
Acquisitions
YoY Change
Other Investing Activities	$23.17M	$26.72M	-$4.260M
YoY Change	-711.35%	-727.23%	-85.4%
Cash From Investing Activities	$23.01M	$26.49M	-$4.860M
YoY Change	-694.57%	-645.06%	-83.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.100M	1.110M	10.38M
YoY Change	-52.82%	-89.31%	521.56%
NET CHANGE
Cash From Operating Activities	-8.790M	-11.86M	-11.74M
Cash From Investing Activities	23.01M	26.49M	-4.860M
Cash From Financing Activities	6.100M	1.110M	10.38M
Net Change In Cash	20.32M	15.74M	-6.220M
YoY Change	4625.58%	-353.05%	-81.62%
FREE CASH FLOW
Cash From Operating Activities	-$8.790M	-$11.86M	-$11.74M
Capital Expenditures	-$160.0K	-$230.0K	-$600.0K
Free Cash Flow	-$8.630M	-$11.63M	-$11.14M
YoY Change	0.94%	4.4%	91.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	us-gaap	Share Price SharePrice	5.50
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22343000
CY2014Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1800000
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	818000
CY2015Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2424000
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19918000
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4046000
CY2015Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	21700000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14447000	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.25
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6892000
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6428000
CY2015Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	2424000
CY2015Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	583000
CY2015Q3	us-gaap	Assets Current AssetsCurrent	128423000
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	953000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	95521000
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	135188000
CY2015Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	18407000
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11323000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.13
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10485000
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	127000
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8108000
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0
CY2015Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1300000
CY2015Q3	us-gaap	Liabilities Liabilities	39667000
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3050000
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3630000
CY2015Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1026000
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	97000
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	673653000
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	7690000
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1215000
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	306000
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4827000
CY2015Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	1449000
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	20000000
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2277000
CY2015Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	697000
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-583056000
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2424000
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6813000
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	98821000
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	623000
CY2015Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8983000
CY2015Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	400000
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3712000
CY2015Q3	us-gaap	Goodwill Goodwill	1316000
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	91142000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	91137000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2015Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1535000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	991000
CY2015Q3	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	7684000
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50795000
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	91137000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2015Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2015Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3859000
CY2015Q3	us-gaap	Assets Assets	135188000
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11000
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5646000
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	91142000
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	123000
CY2015Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	91142000
CY2015Q3	us-gaap	Inventory Net InventoryNet	12842000
CY2015Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	48968000
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest In Year Four LongTermDebtMaturitiesRepaymentsOfInterestInYearFour	517000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest	24672000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest LongTermDebtMaturitiesRepaymentsOfInterest	4672000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest In Year Five LongTermDebtMaturitiesRepaymentsOfInterestInYearFive	1474000
CY2015Q3	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	63000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo	4402000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfInterestRemainderOfFiscalYear	349000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest In Year Three LongTermDebtMaturitiesRepaymentsOfInterestInYearThree	980000
CY2015Q3	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	81000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree	7408000
CY2015Q3	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	18488000
CY2015Q3	cers	Options And Other Stock Based Awards OptionsAndOtherStockBasedAwards	14500000	shares
CY2015Q3	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour	7409000
CY2015Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	100000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Interest In Year Two LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo	1352000
CY2015Q3	cers	Accrued Inventory AccruedInventory	92000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestRemainderOfFiscalYear	349000
CY2015Q3	cers	Long Term Debt Maturities Repayments Of Principal And Interest In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive	5104000
CY2015Q3	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	1512000
CY2015Q3	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	413000
CY2015Q3	cers	Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent	500000
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	97138029	shares
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5699000
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5493000
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	33457000
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29187000
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3951000
CY2014Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	10485000
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	115000
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8444000
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2014Q4	us-gaap	Liabilities Liabilities	40255000
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	875000
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	80000
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	583416000
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1081000
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	376000
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-31000
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2123000
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	851000
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-541944000
CY2014Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	264000
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	41521000
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81776000
CY2014Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9872000
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10485000
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9882000
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	33426000
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	508000
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12734000
CY2014Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	1300000
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3781000
CY2014Q4	us-gaap	Assets Current AssetsCurrent	74885000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5705000
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1932000
CY2014Q4	us-gaap	Goodwill Goodwill	1316000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	27752000
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	27727000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1210000
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1142000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22781000
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	33426000
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2222000
CY2014Q4	us-gaap	Assets Assets	81776000
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.57
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95347000	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-31574000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	632000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18483000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-32836000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1241000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3446000
	us-gaap	Operating Expenses OperatingExpenses	43805000
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	144000
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	33457000
CY2014Q4	us-gaap	Inventory Net InventoryNet	14956000
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	28513000
CY2014Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	128000
CY2014Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	10000000
CY2014Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	1	Customer
CY2014Q4	cers	Accrued Inventory AccruedInventory	870000
CY2014Q4	cers	Accrued Customer Costs And Deposits Current AccruedCustomerCostsAndDepositsCurrent	385000
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2030000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73407000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31177000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75437000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2860000
	us-gaap	Payments For Royalties PaymentsForRoyalties	1900000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-945000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18591000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2033000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	106000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	14807000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-50000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	26829000
	us-gaap	Dilutive Securities DilutiveSecurities	-14263000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13091000
	us-gaap	Net Income Loss NetIncomeLoss	-18573000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-65000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	6000000
	us-gaap	Gross Profit GrossProfit	12231000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-18000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Interest Expense InterestExpense	333000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6849000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	23520000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Cost Of Revenue CostOfRevenue	14598000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	989000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17305000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9848000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	16614000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10269000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	379000
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14263000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7142000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3764000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1555000
	us-gaap	Share Based Compensation ShareBasedCompensation	3764000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27040000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2728000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	515000
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	14300000
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	13900000
	dei	Document Type DocumentType	10-Q
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	41000	shares
	dei	Trading Symbol TradingSymbol	CERS
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	993000	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Certain reclassifications have been made to prior period reported amounts to conform to the current period presentations. Previously the Company had presented the amortization of premium and accretion of any discount resulting from the purchase of fixed income securities as a component of “Interest expense” on the unaudited condensed consolidated statements of operations. For the three and nine months ended September 30, 2014, the Company has reclassified approximately $0.1 million and $0.3 million, respectively, of the amortization of premium resulting from the purchase of fixed income securities as a component of “Other income, net” on the unaudited condensed consolidated statements of operations. This reclassification had no impact on net loss, total assets or total stockholders’ equity.</p> </div>
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	155000	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; PAGE-BREAK-BEFORE: always; MARGIN-TOP: 0pt"> </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and non-equity short-term investments are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments are investment grade and carry high credit quality ratings, which is in accordance with its investment policy. At September 30, 2015, the fair value of the Company’s marketable equity securities of Aduro is subject to the underlying volatility of Aduro’s stock price. At September 30, 2015, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">  </p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses. At September 30, 2015 and December 31, 2014, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company had two and one customer that accounted for more than 10% of the Company’s outstanding trade receivables at each of September 30, 2015 and December 31, 2014, respectively. These customers cumulatively represented approximately 42% and 36% of the Company’s outstanding trade receivables at September 30, 2015 and December 31, 2014, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The Company's US federal and California tax years through 2014 remain subject to examination by the taxing jurisdictions due to unutilized net operating losses and research credits.
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-42344000
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.73
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.91
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	308000	shares
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims are probable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims and did not carry a warranty claim liability at September 30, 2015 and December 31, 2014.</p> </div>
	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.57
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96340000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3628000	shares
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-802000
	us-gaap	Payments For Royalties PaymentsForRoyalties	1900000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-624000
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36254000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	36000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	78261000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-46082000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1970000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43033000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-45810000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	153000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	115000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	85000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	24567000
	us-gaap	Dilutive Securities DilutiveSecurities	-4698000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3049000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4912000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3085000
	us-gaap	Share Based Compensation ShareBasedCompensation	4912000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34713000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-375000
CY2014Q3	us-gaap	Dilutive Securities DilutiveSecurities	-1738000
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	600000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-10759000
CY2014Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	2200000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-4698000
	us-gaap	Net Income Loss NetIncomeLoss	-41112000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-230000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	1500000
	us-gaap	Gross Profit GrossProfit	7265000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4858000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Interest Expense InterestExpense	1061000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75327000
	us-gaap	Operating Expenses OperatingExpenses	53347000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	91851000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Cost Of Revenue CostOfRevenue	17302000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2852000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1229000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1921000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	57444000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	18483000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6609000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-42000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4698000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	3363000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28014000
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-21493000
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
CY2014Q3	us-gaap	Gross Profit GrossProfit	4673000
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	4700000
	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	12500000
	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2020
	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
	cers	Excess Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities ExcessTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities	2034000
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14636363	shares
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5100000
CY2015Q1	cers	Estimated Net Proceeds From Public Offering EstimatedNetProceedsFromPublicOffering	75400000
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	909000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75194000	shares
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76103000	shares
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2014Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	600000
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-941000
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10776000
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	52000
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11351000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10751000
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12497000
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10362000
CY2015Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1734000
CY2015Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10932000
CY2015Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7689000
CY2014Q3	us-gaap	Interest Expense InterestExpense	249000
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	16024000
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	5689000
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000
CY2014Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7250000
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1738000
CY2014Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1478000
CY2014Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8724000
CY2014Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
CY2014Q3	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	1700000
CY2014Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4300000
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	741000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96864000	shares
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97605000	shares
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2015Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	700000
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-10000
CY2015Q3	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18334000
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16186000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15585000
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16789000
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8045000
CY2015Q3	us-gaap	Dilutive Securities DilutiveSecurities	-1109000
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	601000
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-15680000
CY2015Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	500000
CY2015Q3	us-gaap	Gross Profit GrossProfit	2485000
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2654000
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2015Q3	us-gaap	Interest Expense InterestExpense	505000
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	18671000
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	5560000
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-1700000
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	95000
CY2015Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1109000
CY2015Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	3000000
CY2015Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2015Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0
CY2015Q3	cers	Warrant Liability Revaluation Gain Loss WarrantLiabilityRevaluationGainLoss	1100000

Files In Submission

Name	View Source	Status
0001193125-15-370158-index-headers.html	Edgar Link	pending
0001193125-15-370158-index.html	Edgar Link	pending
0001193125-15-370158.txt	Edgar Link	pending
0001193125-15-370158-xbrl.zip	Edgar Link	pending
cers-20150930.xml	Edgar Link	completed
cers-20150930.xsd	Edgar Link	pending
cers-20150930_cal.xml	Edgar Link	unprocessable
cers-20150930_def.xml	Edgar Link	unprocessable
cers-20150930_lab.xml	Edgar Link	unprocessable
cers-20150930_pre.xml	Edgar Link	unprocessable
d17489d10q.htm	Edgar Link	pending
d17489dex101.htm	Edgar Link	pending
d17489dex102.htm	Edgar Link	pending
d17489dex311.htm	Edgar Link	pending
d17489dex312.htm	Edgar Link	pending
d17489dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
CERUS CORP Stock $cers

2015 Q4 Form 10-Q Financial Statement

#000119312515370158 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS CERUS CORP Stock $cers

2015 Q4 Form 10-Q Financial Statement

#000119312515370158 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
CERUS CORP Stock $cers